DE69705108D1 - Mischungen ausgehend von eugenia jambolana lamarck samen, herstellung und verwendung solcher mischungen sowie einiger inhaltsstoffe als medikamente - Google Patents

Mischungen ausgehend von eugenia jambolana lamarck samen, herstellung und verwendung solcher mischungen sowie einiger inhaltsstoffe als medikamente

Info

Publication number
DE69705108D1
DE69705108D1 DE69705108T DE69705108T DE69705108D1 DE 69705108 D1 DE69705108 D1 DE 69705108D1 DE 69705108 T DE69705108 T DE 69705108T DE 69705108 T DE69705108 T DE 69705108T DE 69705108 D1 DE69705108 D1 DE 69705108D1
Authority
DE
Germany
Prior art keywords
mixtures
medicines
ingredients
production
eugenia jambolana
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69705108T
Other languages
English (en)
Other versions
DE69705108T2 (de
Inventor
Ratsimamanga Albert Rakoto
Ratsimamanga Suzanne Rakoto
Philippe Rasoanaivo
Jean Leboul
Jean Provost
Daniel Reisdorf
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Aventis Pharma SA
INST MALGACHE DE RECH S APPLIQ
Original Assignee
Aventis Pharma SA
INST MALGACHE DE RECH S APPLIQ
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma SA, INST MALGACHE DE RECH S APPLIQ filed Critical Aventis Pharma SA
Publication of DE69705108D1 publication Critical patent/DE69705108D1/de
Application granted granted Critical
Publication of DE69705108T2 publication Critical patent/DE69705108T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
    • C07D241/02—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
    • C07D241/10—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D241/12—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/61—Myrtaceae (Myrtle family), e.g. teatree or eucalyptus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
    • A61P5/50—Drugs for disorders of the endocrine system of the pancreatic hormones for increasing or potentiating the activity of insulin

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Diabetes (AREA)
  • Microbiology (AREA)
  • Botany (AREA)
  • Mycology (AREA)
  • Biotechnology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Medical Informatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Endocrinology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Emergency Medicine (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Steroid Compounds (AREA)
  • Treatment Of Liquids With Adsorbents In General (AREA)
  • Tea And Coffee (AREA)
DE69705108T 1996-02-06 1997-02-03 Mischungen ausgehend von eugenia jambolana lamarck samen, herstellung und verwendung solcher mischungen sowie einiger inhaltsstoffe als medikamente Expired - Lifetime DE69705108T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9601389A FR2744365B1 (fr) 1996-02-06 1996-02-06 Melanges isolables a partir de graines d'eugenia jambolana lamarck, leur preparation et l'utilisation de ces melanges et certains de leurs constituants comme medicaments
PCT/FR1997/000207 WO1997028813A1 (fr) 1996-02-06 1997-02-03 Melanges isolables a partir de graines d'eugenia jambolana lamarck, leur preparation et l'utilisation de ces melanges et certains de leurs constituants comme medicaments

Publications (2)

Publication Number Publication Date
DE69705108D1 true DE69705108D1 (de) 2001-07-12
DE69705108T2 DE69705108T2 (de) 2001-12-20

Family

ID=9488865

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69705108T Expired - Lifetime DE69705108T2 (de) 1996-02-06 1997-02-03 Mischungen ausgehend von eugenia jambolana lamarck samen, herstellung und verwendung solcher mischungen sowie einiger inhaltsstoffe als medikamente

Country Status (34)

Country Link
US (4) US5972342A (de)
EP (1) EP0879058B1 (de)
JP (2) JP4570694B2 (de)
KR (1) KR100494625B1 (de)
CN (2) CN1080566C (de)
AR (1) AR005726A1 (de)
AT (1) ATE201826T1 (de)
AU (1) AU726628B2 (de)
BG (1) BG63288B1 (de)
BR (1) BR9707613A (de)
CA (1) CA2245701C (de)
CZ (1) CZ292800B6 (de)
DE (1) DE69705108T2 (de)
DK (1) DK0879058T3 (de)
DZ (1) DZ2174A1 (de)
EA (1) EA001463B1 (de)
ES (1) ES2158496T3 (de)
FR (1) FR2744365B1 (de)
GR (1) GR3036007T3 (de)
HU (1) HU227958B1 (de)
IL (1) IL125598A (de)
MA (1) MA24077A1 (de)
NO (1) NO318694B1 (de)
NZ (1) NZ331241A (de)
PL (1) PL186798B1 (de)
PT (1) PT879058E (de)
RS (1) RS49527B (de)
SK (1) SK282672B6 (de)
TN (1) TNSN97031A1 (de)
TR (1) TR199801490T2 (de)
TW (1) TW528598B (de)
UA (1) UA60299C2 (de)
WO (1) WO1997028813A1 (de)
ZA (1) ZA97910B (de)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE252089T1 (de) 1997-07-17 2003-11-15 Aventis Pharma Sa Polyhydroxyalkylpyrazine derivate,deren herstellung und diese enthaltende arzneimitteln
FR2766180A1 (fr) * 1997-07-17 1999-01-22 Rhone Poulenc Rorer Sa Medicaments contenant en tant que principe actif un derive de 2-(1,2,3,4-tetrahydroxybutyl)pyrazine,nouveaux derives de 2-(1,2,3,4-tetrahydroxybutyl) pyrazine et leur preparation
FR2766182A1 (fr) * 1997-07-17 1999-01-22 Rhone Poulenc Rorer Sa Medicaments contenant des derives de polyhydroxyalkylpyrazine, les nouveaux derives de polyhydroxyalkylpyrazine et leur preparation
FR2766184B1 (fr) * 1997-07-17 2000-11-17 Rhone Poulenc Rorer Sa Medicaments contenant en tant que principe actif au moins un derive de polyhydroxylalkylpyrazine, les nouveaux derives de polyhydroxylalkylpyrazine et leur preparation
FR2766183B1 (fr) * 1997-07-17 1999-08-27 Rhone Poulenc Rorer Sa Medicaments contenant des polyhydroxybutylpyrazines, les polyhydroxybutylpyrazines nouvelles et leur preparation
FR2766185B1 (fr) 1997-07-18 2001-06-15 Rhone Poulenc Rorer Sa Medicaments contenant en tant que principe actif au moins un derive substitue de polyhydroxylalkylpyrazines, les nouveaux derives polyhydroxylalkylpyrazines et leur preparation
FR2781155B1 (fr) * 1998-07-16 2001-10-26 Rhone Poulenc Rorer Sa Medicaments contenant des derives de polyhydroxyalkylpyrazine, les nouveaux derives de polyhydroxyalkylpyrazine et leur preparation
FR2788274B1 (fr) * 1999-01-11 2001-02-09 Aventis Pharma Sa Nouveaux derives de polyhydroxypyrazines, leur preparation et les compositions pharmaceutiques qui les contiennent
AU5844300A (en) * 1999-06-04 2000-12-28 Indian Council Of Medical Research Eugenia jambolina fruit extracts for treating diabetes
US7338955B1 (en) * 1999-10-12 2008-03-04 Lilly Icos Llc Medicament for treatment of neuropathies
FR2802814B1 (fr) * 1999-12-23 2002-02-22 Aventis Pharma Sa Association de deoxyfructosazine et d'un antidiabetique de la famille des sulfonylurees
FR2803515B1 (fr) * 2000-01-06 2002-08-02 Aventis Pharma Sa Solution aqueuse stable de deoxyfructosazine
AUPQ987400A0 (en) * 2000-09-04 2000-09-28 Food Ingredients Technologies Intangibles (Bermuda) Limited Process for selectively extracting bioactive components
US20050255180A1 (en) * 2004-05-14 2005-11-17 Gaurav Tewari Prevention of diabetes by medicinal plants & fruits
JP4615256B2 (ja) * 2004-06-03 2011-01-19 株式会社エヌ・ティー・エイチ フトモモ科植物の含有成分とその用途
US20060266975A1 (en) * 2005-05-27 2006-11-30 Nappa Mario J Compositions comprising 3,3,4,4,5,5,6,6,6-nonafluoro-1-hexene
WO2008004119A2 (en) * 2006-07-06 2008-01-10 Avestha, Gengraine, Technologies, Pvt., Ltd. Eugenia jambolana plant extracts for treating osteoporosis and the extraction process thereof
CN102552231A (zh) * 2011-12-23 2012-07-11 苏州大学 草氨酸钠在制备fto酶抑制剂和减肥药物中的应用
CN113367166B (zh) * 2021-05-13 2022-07-26 海南大学 一种褐背蒲桃提取物杀菌剂及其制备方法和应用

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR6114M (de) * 1967-01-19 1968-06-17
US3660571A (en) * 1968-03-28 1972-05-02 Takeda Chemical Industries Ltd Disease control composition for silkworms
DE2159923C3 (de) * 1971-12-02 1974-05-22 Schwabe, Willmar, Dr., 7500 Karlsruhe-Durlach Verfahren zur Gewinnung eines Stoffes mit insulinähnlicher Wirkung und diese Stoffe enthaltende Arzneipräparate
JPS5390401A (en) * 1977-01-13 1978-08-09 Japan Tobacco & Salt Public Improving of smoking taste of cigarette
FR2465484A1 (fr) * 1979-09-21 1981-03-27 Urwerg Suzanne Extrait vegetal a proprietes antidiabetiques et son procede de preparation

Also Published As

Publication number Publication date
BG102673A (en) 1999-09-30
ZA97910B (en) 1997-08-01
YU4197A (sh) 1999-07-28
ES2158496T3 (es) 2001-09-01
IL125598A (en) 2002-04-21
US6300375B1 (en) 2001-10-09
HUP9902586A3 (en) 2000-01-28
FR2744365B1 (fr) 1998-02-27
ATE201826T1 (de) 2001-06-15
EA199800692A1 (ru) 1999-02-25
JP4570694B2 (ja) 2010-10-27
FR2744365A1 (fr) 1997-08-08
IL125598A0 (en) 1999-03-12
AR005726A1 (es) 1999-07-14
UA60299C2 (uk) 2003-10-15
RS49527B (sr) 2006-12-15
JP2001500103A (ja) 2001-01-09
NO983592L (no) 1998-08-05
CN1148178C (zh) 2004-05-05
JP2010053133A (ja) 2010-03-11
NO318694B1 (no) 2005-04-25
TW528598B (en) 2003-04-21
AU726628B2 (en) 2000-11-16
DK0879058T3 (da) 2001-09-03
TR199801490T2 (xx) 1998-10-21
EP0879058A1 (de) 1998-11-25
GR3036007T3 (en) 2001-09-28
HU227958B1 (en) 2012-07-30
AU1727197A (en) 1997-08-28
CZ243698A3 (cs) 1998-11-11
US20020051828A1 (en) 2002-05-02
CZ292800B6 (cs) 2003-12-17
KR100494625B1 (ko) 2005-09-30
CN1210469A (zh) 1999-03-10
BG63288B1 (bg) 2001-09-28
CN1080566C (zh) 2002-03-13
PL186798B1 (pl) 2004-02-27
US5972342A (en) 1999-10-26
SK282672B6 (sk) 2002-11-06
MA24077A1 (fr) 1997-10-01
CA2245701C (fr) 2007-09-25
HUP9902586A2 (hu) 1999-12-28
SK105298A3 (en) 1998-12-02
EA001463B1 (ru) 2001-04-23
PT879058E (pt) 2001-10-31
WO1997028813A1 (fr) 1997-08-14
CN1325685A (zh) 2001-12-12
BR9707613A (pt) 1999-07-27
NO983592D0 (no) 1998-08-05
US6194412B1 (en) 2001-02-27
DE69705108T2 (de) 2001-12-20
CA2245701A1 (fr) 1997-08-14
DZ2174A1 (fr) 2002-12-01
TNSN97031A1 (fr) 1999-12-31
PL328415A1 (en) 1999-01-18
KR19990082343A (ko) 1999-11-25
NZ331241A (en) 1999-09-29
EP0879058B1 (de) 2001-06-06
JP5033857B2 (ja) 2012-09-26

Similar Documents

Publication Publication Date Title
DE69705108T2 (de) Mischungen ausgehend von eugenia jambolana lamarck samen, herstellung und verwendung solcher mischungen sowie einiger inhaltsstoffe als medikamente
BR9704843B1 (pt) hidroxifeniltriazinas, composiÇço, processo de estabilizaÇço de material orgÂnico, uso, preparaÇço cosmÉtica e processo de tratamento de cabelo humano.
DE122008000020I1 (de) Disubstituierte bicyclische heterocyclen, ihre herstellung und ihre verwendung als arzneimittel
DE69715482D1 (de) Herstellung von 1,1,1,3,3-Pentachlorbutan und von 1,1,1,3,3-Pentafluorbutan
DE69414680T2 (de) Kosmetische anwendung von lipophiles derivates von aminodeoxyalditoles, diese enthaltende kosmetische zusammensetzungen und alkylcarbamates
NO980715L (no) Antipruriginöse, kosmetiske og/eller farmasöytiske sammensetninger bestående av en eller flere lette lokale anestesimider og en eller flere astringente forbindelser
DE69600879D1 (de) Verwendung von fumagillol und seinen derivaten zur herstellung von arzneimitteln gegen darminfektionen
DE69328528D1 (de) D-Ketohexose-3-Epimerase, und seine Herstellung und Verwendung
ATE224910T1 (de) Derivate von dolestatin, deren herstellung und verwendung
ATE215373T1 (de) 21-hydro-6,19-oxidoprogesterone (21oh-60p) und deren verwendung als arzneimittel zur behandlung von glukokortikoidüberschuss
DE59609208D1 (de) Herstellung von Mischkristallen und festen Lösungen von 1,4-Diketopyrrolopyrrolen
DE59606486D1 (de) Herstellung von Poly-o-hydroxyamiden und Poly-o-mercaptoamiden
DE69533739D1 (de) Herstellung von Triorganozinn-Lithium-Zusammensetzungen und deren Verwendung als Initiatoren
DE69727240D1 (de) Kombinationen enthaltend vx478, zidovudin und 3tc zur behandlung von hiv
DE69612895D1 (de) Haarfärbemittel, enthaltend zerdrückte Impatiens-Balsamina-Pflanzen oder -Pflanzenteile, und dessen Verwendung
DE69700062T2 (de) Verfahren zur Herstellung von UV-Filtern enthaltende Zusammensetzungen, Zusammensetzung und Verwendung
ATE226956T1 (de) Alpha-d-xylose verbindungen, herstellung und verwendung als arzneimitteln
DE59711240D1 (de) Verwendung von flupirtin zur therapie und prophylaxe von myokardinfarkt, schockniere und schocklunge
DE59812095D1 (de) Verwendung von detergensgemischen enthaltend esterquats und alkoxylierte feesäureamidoamine zur herstellung von kosmetischen zubereitungen
DE69523404D1 (de) Verwendung von dihydrobenzofuranonen als parfüminhaltstoffe
DE69400585D1 (de) Herstellung von gemischten Pulvern
DE69730766D1 (de) Maltooligosyltaranose und Maltooligosylparatinose enthaltende Polysaccharidzusammensetzung, Herstellung und Verwendung
DE59606492D1 (de) Herstellung von Poly-o-hydroxyamiden und Poly-o-mercaptoamiden
FR2707492B1 (fr) Nouvelles compositions cosmétiques ou dermatologiques renfermant les ribosomes, préparation des ribosomes, préparation desdites compositions et leur application.
FR2747309B1 (fr) Nouvelles compositions destinees aux traitements des brulures et blessures, contenant differents acylaminoacides et lipoylaminoacides

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8328 Change in the person/name/address of the agent

Representative=s name: PFENNING MEINIG & PARTNER GBR, 80339 MUENCHEN

8328 Change in the person/name/address of the agent

Representative=s name: MAIWALD PATENTANWALTSGESELLSCHAFT MBH, 80335 MUENC